Biond develops organ-on-chip microchips that recreate key aspects of human organs, enabling researchers to nourish, stimulate, and monitor complex 3D tissues for biomedical studies. This technology provides a viable alternative to animal testing, facilitating drug discovery and development while addressing the limitations of traditional research methods.
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
FOFounders
Product
Problem
Traditional methods of biomedical research, including animal testing, often fail to accurately replicate the complexities of human organs and tissues. This can lead to ineffective drug development and a limited understanding of human physiology and disease. Current in-vitro methods often lack the ability to mimic the 3D structure and microenvironment of living tissues.
Solution
Bi/ond develops organ-on-chip microfluidic devices that recreate key aspects of human organs, enabling researchers to study complex 3D tissues in a controlled, in-vitro environment. These microchips, combined with a smart well-plate, allow for the nourishment, stimulation, and monitoring of cells, providing a more physiologically relevant model for biomedical studies. Bi/ond's technology facilitates drug discovery and development by offering a viable alternative to animal testing and addressing the limitations of traditional research methods. The platform supports the cultivation of complex 3D tissues, including organoids, ex vivo tissue, spheroids, and microtissues, as well as tissue-tissue interface models.
Target Audience
The primary target audience includes researchers and scientists in pharmaceutical and biotech companies, as well as Contract Research Organizations (CROs), focused on drug discovery, toxicology, and basic biological research.
Features
- **inCHIPit™:** An organ-on-chip solution for nourishing, stimulating, and monitoring complex 3D tissues when combined with the comPLATE™.
- **MUSbit™:** A microfluidic chip designed for studying (heart) muscle tissue, also used in conjunction with the comPLATE™.
- **comPLATE™:** A smart well-plate that complements Bi/ond's chips to provide a comprehensive cell culture environment.
- Microfluidic channels for precise control over nutrient delivery and waste removal.
- Capability to recreate tissue interactions and blood circulation within the microchip.
- Versatile platform suitable for various applications, including (heart & skeletal) muscle, organoids, and tumor tissue research.